UMIN-CTR Clinical Trial

Recruitment status Completed
Unique ID issued by UMIN UMIN000049397
Receipt No. R000056247
Scientific Title Single intracavernous injection of autologous adipose-derived stem cells versus a single high dose of Platelet Rich Plasma to improve erectile dysfunction
Date of disclosure of the study information 2022/11/02
Last modified on 2022/11/02 (Ver. 1)

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Public title Single intracavernous injection of autologous adipose-derived stem cells versus a single high dose of Platelet Rich Plasma to improve erectile dysfunction: A comparative study
Acronym SICIADSCVSSIPRPTEDCS
Scientific Title Single intracavernous injection of autologous adipose-derived stem cells versus a single high dose of Platelet Rich Plasma to improve erectile dysfunction
Scientific Title:Acronym SICIADSCVSSIPRPTED
Region
Asia(except Japan)

Condition
Condition Erectile dysfunction
Classification by specialty
Urology
Classification by malignancy Others
Genomic information NO

Objectives
Narrative objectives1 compare the efficacy and safety of single high dose PRP intracavernous injection and single dose of Adipose mesenchymal Stem Cells (ADSC) in patients with severe ED.
Basic objectives2 Safety
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase

Assessment
Primary outcomes effectiveness of single high dose PRP intracavernous injection and single dose of Adipose mesenchymal Stem Cells (ADSC) in patients with severe ED.
Key secondary outcomes

Base
Study type Interventional

Study design
Basic design Parallel
Randomization Randomized
Randomization unit Individual
Blinding Single blind -investigator(s) and assessor(s) are blinded
Control Active
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms 2
Purpose of intervention Treatment
Type of intervention
Other
Interventions/Control_1 Adipose mesenchymal Stem Cells (ADSC)

Single dose

Intracavernous injections
Interventions/Control_2 Platelet rich plasma (PRP)

Single dose

Intracavernous injections
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit
60 years-old <=
Age-upper limit
70 years-old >=
Gender Male
Key inclusion criteria male with severe ED refractory to conventional therapies
Key exclusion criteria male with mild to moderate ED
Target sample size 20

Research contact person
Name of lead principal investigator
1st name Mohamad
Middle name
Last name Abou Chakra
Organization Al Zahraa Hospital-Stem cell institute
Division name Urology
Zip code 1108
Address Beirut, Lebanon
TEL 0096171613732
Email mohamedabouchakra@hotmail.com

Public contact
Name of contact person
1st name Mohamad
Middle name
Last name Moussa
Organization Al Zahraa Hospital, Stem Cell institute
Division name Urology
Zip code 1108
Address Beirut, Lebanon
TEL 009613964412
Homepage URL
Email mohamadamoussa@hotmail.com

Sponsor
Institute Al Zahraa Hospital
Institute
Department

Funding Source
Organization None
Organization
Division
Category of Funding Organization Self funding
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

IRB Contact (For public release)
Organization Al Zahraa Hospital
Address Beirut, Lebanon
Tel 009611850040ext3365
Email IRB-zahraa@outlook.com

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions

Other administrative information
Date of disclosure of the study information
2022 Year 11 Month 02 Day

Related information
URL releasing protocol
Publication of results Unpublished

Result
URL related to results and publications
Number of participants that the trial has enrolled 20
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description

Progress
Recruitment status Completed
Date of protocol fixation
2019 Year 08 Month 17 Day
Date of IRB
2020 Year 01 Month 20 Day
Anticipated trial start date
2020 Year 01 Month 25 Day
Last follow-up date
2022 Year 08 Month 18 Day
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Other
Other related information

Management information
Registered date
2022 Year 11 Month 02 Day
Last modified on
2022 Year 11 Month 02 Day


Link to view the page
URL(English) https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000056247